These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 29636068)
1. Iron-dependent cell death as executioner of cancer stem cells. Zhao B; Li X; Wang Y; Shang P J Exp Clin Cancer Res; 2018 Apr; 37(1):79. PubMed ID: 29636068 [TBL] [Abstract][Full Text] [Related]
2. An iron hand over cancer stem cells. Hamaï A; Cañeque T; Müller S; Mai TT; Hienzsch A; Ginestier C; Charafe-Jauffret E; Codogno P; Mehrpour M; Rodriguez R Autophagy; 2017 Aug; 13(8):1465-1466. PubMed ID: 28613094 [TBL] [Abstract][Full Text] [Related]
3. Salinomycin kills cancer stem cells by sequestering iron in lysosomes. Mai TT; Hamaï A; Hienzsch A; Cañeque T; Müller S; Wicinski J; Cabaud O; Leroy C; David A; Acevedo V; Ryo A; Ginestier C; Birnbaum D; Charafe-Jauffret E; Codogno P; Mehrpour M; Rodriguez R Nat Chem; 2017 Oct; 9(10):1025-1033. PubMed ID: 28937680 [TBL] [Abstract][Full Text] [Related]
4. DMT1 Inhibitors Kill Cancer Stem Cells by Blocking Lysosomal Iron Translocation. Turcu AL; Versini A; Khene N; Gaillet C; Cañeque T; Müller S; Rodriguez R Chemistry; 2020 Jun; 26(33):7369-7373. PubMed ID: 32083771 [TBL] [Abstract][Full Text] [Related]
5. Salinomycin Derivatives Kill Breast Cancer Stem Cells by Lysosomal Iron Targeting. Versini A; Colombeau L; Hienzsch A; Gaillet C; Retailleau P; Debieu S; Müller S; Cañeque T; Rodriguez R Chemistry; 2020 Jun; 26(33):7416-7424. PubMed ID: 32083773 [TBL] [Abstract][Full Text] [Related]
6. Salinomycin-Loaded Gold Nanoparticles for Treating Cancer Stem Cells by Ferroptosis-Induced Cell Death. Zhao Y; Zhao W; Lim YC; Liu T Mol Pharm; 2019 Jun; 16(6):2532-2539. PubMed ID: 31009228 [TBL] [Abstract][Full Text] [Related]
7. Salinomycin induces apoptosis in cisplatin-resistant colorectal cancer cells by accumulation of reactive oxygen species. Zhou J; Li P; Xue X; He S; Kuang Y; Zhao H; Chen S; Zhi Q; Guo X Toxicol Lett; 2013 Oct; 222(2):139-45. PubMed ID: 23916687 [TBL] [Abstract][Full Text] [Related]
9. Persister cancer cells: Iron addiction and vulnerability to ferroptosis. Rodriguez R; Schreiber SL; Conrad M Mol Cell; 2022 Feb; 82(4):728-740. PubMed ID: 34965379 [TBL] [Abstract][Full Text] [Related]
10. Salinomycin induced ROS results in abortive autophagy and leads to regulated necrosis in glioblastoma. Xipell E; Gonzalez-Huarriz M; Martinez de Irujo JJ; García-Garzón A; Lang FF; Jiang H; Fueyo J; Gomez-Manzano C; Alonso MM Oncotarget; 2016 May; 7(21):30626-41. PubMed ID: 27121320 [TBL] [Abstract][Full Text] [Related]
11. A promising new approach to cancer therapy: Targeting iron metabolism in cancer stem cells. El Hout M; Dos Santos L; Hamaï A; Mehrpour M Semin Cancer Biol; 2018 Dec; 53():125-138. PubMed ID: 30071257 [TBL] [Abstract][Full Text] [Related]
12. Dysregulation of iron metabolism in cancer stem cells. Recalcati S; Gammella E; Cairo G Free Radic Biol Med; 2019 Mar; 133():216-220. PubMed ID: 30040994 [TBL] [Abstract][Full Text] [Related]
13. The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor. Riccioni R; Dupuis ML; Bernabei M; Petrucci E; Pasquini L; Mariani G; Cianfriglia M; Testa U Blood Cells Mol Dis; 2010 Jun; 45(1):86-92. PubMed ID: 20444629 [TBL] [Abstract][Full Text] [Related]
14. Salinomycin possesses anti-tumor activity and inhibits breast cancer stem-like cells via an apoptosis-independent pathway. An H; Kim JY; Lee N; Cho Y; Oh E; Seo JH Biochem Biophys Res Commun; 2015 Oct; 466(4):696-703. PubMed ID: 26407842 [TBL] [Abstract][Full Text] [Related]
15. Salinomycin exerts anticancer effects on human breast carcinoma MCF-7 cancer stem cells via modulation of Hedgehog signaling. Lu Y; Ma W; Mao J; Yu X; Hou Z; Fan S; Song B; Wang H; Li J; Kang L; Liu P; Liu Q; Li L Chem Biol Interact; 2015 Feb; 228():100-7. PubMed ID: 25499043 [TBL] [Abstract][Full Text] [Related]
16. Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin. Kai M; Kanaya N; Wu SV; Mendez C; Nguyen D; Luu T; Chen S Breast Cancer Res Treat; 2015 Jun; 151(2):281-94. PubMed ID: 25904215 [TBL] [Abstract][Full Text] [Related]
17. Semi-synthetic salinomycin analogs exert cytotoxic activity against human colorectal cancer stem cells. Klose J; Kattner S; Borgström B; Volz C; Schmidt T; Schneider M; Oredsson S; Strand D; Ulrich A Biochem Biophys Res Commun; 2018 Jan; 495(1):53-59. PubMed ID: 29107689 [TBL] [Abstract][Full Text] [Related]
18. Salinomycin Promotes Anoikis and Decreases the CD44+/CD24- Stem-Like Population via Inhibition of STAT3 Activation in MDA-MB-231 Cells. An H; Kim JY; Oh E; Lee N; Cho Y; Seo JH PLoS One; 2015; 10(11):e0141919. PubMed ID: 26528725 [TBL] [Abstract][Full Text] [Related]
19. Semisynthesis of SY-1 for investigation of breast cancer stem cell selectivity of C-ring-modified salinomycin analogues. Huang X; Borgström B; Månsson L; Persson L; Oredsson S; Hegardt C; Strand D ACS Chem Biol; 2014 Jul; 9(7):1587-94. PubMed ID: 24841425 [TBL] [Abstract][Full Text] [Related]
20. Salinomycin: a new cancer drug candidate. Huczynski A Chem Biol Drug Des; 2012 Mar; 79(3):235-8. PubMed ID: 22145602 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]